|
(MoneyNewsWire.Net, November 29, 2017 ) In-vitro fertilization (IVF) involves the fertilization of ovum using laboratory settings followed by implantation into uterus. In-vitro fertilization is also known as assisted reproductive technology. The process involves the collection of matured healthy eggs and sperms from the partners, or known or anonymous donors. These eggs get fertilized using laboratory reagents & media and instruments.
Fertilized eggs (embryos) are implanted into uterus for the continuation of development of embryo to child. One cycle of in-vitro fertilization takes around 10-15 days. IVF is most widely accepted method for the fertility treatments in clinical industry and helpful for the couples with infertility problems, single mothers, as well as LGBT communities. The major product categories that assist in-vitro fertilization method include reagents & media (such as embryo culture media, sperm processing media) and instruments (sperm separation system, cryosystems).
Growing number of delayed pregnancies among women, rising awareness pertaining to infertility consequences, and presence of favorable reimbursement systems are driving the growth of the global in-vitro fertilization market. In addition, increasing technological advancements in in-vitro fertilization procedures (embryoscope & capsule in-vitro fertilization), rising medical tourisms across the major countries, growing gynecological disorders & fertility disorders, increasing focus of clinical research institutes towards the innovation of in-vitro fertilization technologies, and occurrence of lifestyle disorders (obesity & smoking that favor infertility) are further propelling the growth of the global in-vitro fertilization market. However, requirement of high capital & time for the running of in-vitro fertilization procedures, difficulties to maintain the in-vitro fertilization procedures, chances of occurrence multiple pregnancies, presence of ethical issues pertaining to selection of gender population, and unawareness of infertility issues in certain under-developed economies are restraining the growth of the global in-vitro fertilization market.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-in-vitro-fertilization-market-298/request-sample
The Global Market for in-vitro fertilization is broadly categorized based on reagents & media, instruments, technology, end users and Region.
1. Based on reagents & media
• Embryo Culture Media
• Sperm Processing Media
2. Based on instruments
• Sperm Separation System
• Cryosystems
• Incubators
3. Based on Technology
• Intra-Cytoplasmic Sperm Injection
• Pre-Implantation Genetic Diagnosis
4. Based on End User
• Fertility & Surgical Centers
• Hospitals & Research Laboratories
5. Based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
The key players in global in-vitro fertilization market such as, CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.).
About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
